• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

2023 SDPA Fall Conference Recap: Day 3

Catch up on coverage from the third day of the 2023 SDPA Fall Dermatology Conference.

JudyK/Adobe Stock
JudyK/Adobe Stock

Lisa Swanson, MD, PhD: Clinical Pearls in Pediatric Dermatology

Lisa Swanson, MD, PhD, delves into clinical pearls from her SDPA fall conference sessions on infantile hemangiomas and challenging cases in pediatric dermatology.

Tapinarof Cream 1% Led to Rapid Improvements in Itch for Adults With Mild to Severe Plaque Psoriasis

Once daily application of tapinarof cream 1% rapidly improved itch in adult patients with varying plaque psoriasis diseases severity, according to a poster presented at SDPA’s fall conference.

Taking a Comprehensive Approach to Common Vulvar Dermatoses

Olushola Akinshemoyin Vaughn, MD, shared clinical pearls from her work in a vulvar dermatology clinic at the 2023 SDPA fall conference.

Reviewing Common Facial, Bodily Pigmented Dermatoses in Varying Clinical Presentations

Rebecca Vasquez, MD, presented a session on common, overlapping, and complex pigmented dermatoses.

Ami Greene, MD: Tools and Tricks for Beginner to Intermediate Dermoscopy

Ami Greene, MD, discusses her beginner and intermediate SDPA fall conference sessions on dermoscopy.

Case Series Finds No Serious Adverse Events as a Result of Live Attenuated Vaccines in Children Treated With Dupilumab

Investigators said that additional, larger studies are needed to assess the safety of live attenuated vaccine administration for pediatric AD patients being treated with dupilumab.

Make sure to keep up to date with the latest in coverage from the conference and subscribe to Dermatology Times to receive daily email updates.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.